Onasemnogene abeparvovec for treating spinal muscular atrophy type 1 [ID1473]
In development [GID-HST10026] Expected publication date: TBC
In development [GID-HST10026] Expected publication date: TBC
In development [GID-NG10096] Expected publication date: 11 August 2021
In development [GID-NG10148] Expected publication date: 18 May 2022
In development [GID-NG10112] Expected publication date: 09 March 2022
In development [GID-NG10174] Expected publication date: 22 March 2023
In development [GID-NG10098] Expected publication date: TBC
In development [GID-NG10151] Expected publication date: 13 June 2022
In development [GID-NG10111] Expected publication date: 12 April 2021